Skip to NavigationSkip to content

Bruce Given appointed chairman of ICON

Published on: 18/01/10

Irish contract research organisation ICON has appointed Bruce Given chairman.

He succeeds out-going chairman John Climax who co-founded the company in 1990 with former chairman Ronan Lambe, and will retire but remain on ICON’s board.

Given said: “We are extremely grateful for the extraordinary leadership and commitment that John has provided to ICON in his 20 years with the company, first as its co-founder and chief executive, and over the past seven years in his role as chairman.

“His vision and passionate commitment to ICON’s performance, people and clients have been the cornerstones of our success and we are delighted that he will remain on the board to help us forge a successful future for the company. It is an honour to succeed him.”

Given has been an ICON board member since 2004 and was most recently a healthcare products consultant.

From 2002 to 2007 he was president and chief executive of US firm Encysive Pharmaceuticals and prior to that spent nine years at Johnson & Johnson in a variety of roles.

He has also held various executive and senior management positions at Sandoz Pharma, Sandoz Research Institute and Schering-Plough Corporation. Prior to entering the pharmaceutical industry, he was on the medical faculty at the University of Chicago.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches